Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-17-001627
Filing Date
2017-08-11
Accepted
2017-08-11 16:58:17
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nmus_10q.htm 10-Q 326452
2 CERTIFICATION nmus_ex311.htm EX-31.1 7568
3 CERTIFICATION nmus_ex312.htm EX-31.2 7782
4 CERTIFICATION nmus_ex321.htm EX-32.1 3181
5 CERTIFICATION nmus_ex322.htm EX-32.2 3190
  Complete submission text file 0001640334-17-001627.txt   3126213

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nmus-20170630.xml EX-101.INS 577065
7 XBRL TAXONOMY EXTENSION SCHEMA nmus-20170630.xsd EX-101.SCH 38540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nmus-20170630_cal.xml EX-101.CAL 29390
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nmus-20170630_def.xml EX-101.DEF 155020
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmus-20170630_lab.xml EX-101.LAB 326941
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmus-20170630_pre.xml EX-101.PRE 225202
Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 171025827
SIC: 2834 Pharmaceutical Preparations